Directly or indirectly, cancer will touch everyone's lives. There is no greater or more worthwhile challenge than the ongoing battle to develop and improve anti-cancer treatments, for everyone's sake.
|
research publications
University of York
2004/5
YORKSHIRE CANCER RESEARCH P53 RESEARCH GROUP
Director of Unit: Professor J. Milner
Milner, J. (2004)
Death without stress-the stiletto approach against disease.
The Biochemist 26, 16-18.
Allison, S.J. and Milner, J. (2004)
Remodelling chromatin on a global scale: a novel protective function of p53.
Carcinogenesis 25, 1551-1557.
Jiang, M. and Milner, J. (2004)
Selective Silencing of Viral Gene E6 and E7 Expression in HPV-Positive Human Cervical Carcinoma Cells Using Small Interfering RNAs.
Methods in Molecular Biology 292, 401-420.
Jiang, M., Rubbi, C.P. and Milner, J. (2004)
Gel-based application of siRNA to human epithelial cancer cells induces RNAi-dependent apoptosis.
Oligonucleotides 14, 1-10.
Warnock, L. and Raines, S.A. (2004)
Restoration of Wild-Type Conformation to Full-Length and Truncated p53 Proteins.
Cancer Biology & Therapy 3, 634-637.
YCR CANCER RESEARCH UNIT
Director of Unit: Professor N J Maitland
Maitland, N.J., Stanbridge L., and Dussupt, V. (2004)
Targeting Gene Therapy For Prostate Cancer
Current pharmaceutical design 10: 531-555
Richardson, G.D., Robson, G.N., Lang, S.H., Neal, D.E., Maitland, N.J., Collins, A.T. (2004)
CD133, a novel marker for human prostatic epithelial stem cells
Journal of Cell Science 117: 3539-3545
Lipinski, K.S., Djeha, H.A., Gawn, J., Cliffe, S., Maitland, N.J., Palmer, D.H., Mountain, A., Irvine, A.S., Wrighton, C.J. (2004)
Optimization of a synthetic -catenin-dependent promoter for tumour-specific cancer gene therapy
Molecular Therapy 10, 150-161
Department of Chemistry
Head of Department: Professor P.H. Walton
Martina, S. L. X., Taylor, R. J. K. (2004)
New Solid Supported Phosphonate Reagents for the Synthesis of Z-a,b-Unsaturated Esters.
Tetrahedron Lett. 45, 3279-3282.
|